Threshold Pharmaceuticals, Inc.
19Patents
13Active
19Granted
45Portfolio score
Filing activity: Dec 20, 2002 → Dec 10, 2013 · 8 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6979675B2 | Treatment of cancer with 2-deoxyglucose | Human Necessities | 85 | Expired |
| US6989140B2 | Methods for cancer imaging | Human Necessities | 32 | Expired |
| US8299088B2 | Compositions and methods for treating cancer | Performing Operations; Transporting | 20 | Active |
| US7001888B2 | Compositions and methods for treating cancer | Human Necessities | 16 | Expired |
| US7560230B2 | Method for determining susceptibility of tumor to treatment with anti-neoplastic agent | Physics | 8 | Expired |
| US8507464B2 | Phosphoramidate alkylator prodrugs | Human Necessities | 8 | Active |
| US8003625B2 | Phosphoramidate alkylator prodrugs | Human Necessities | 6 | Active |
| US7550496B2 | Compositions and methods for treating cancer | Performing Operations; Transporting | 6 | Expired |
| US8575188B2 | Camptothecin derivatives | Chemistry; Metallurgy | 5 | Active |
| US6989400B2 | Treatment of benign prostatic hyperplasia | Physics | 5 | Expired |
| US8946275B2 | Treatment of cancer using hypoxia activated prodrugs | Human Necessities | 5 | Active |
| US8664204B2 | Phosphoramidate alkylator prodrugs | Human Necessities | 1 | Active |
| US9205098B2 | Anti-cancer therapies | Human Necessities | 1 | Active |
| US9254299B2 | Administration of hypoxia activated prodrugs in combination with Chk1 inhibitors for treating cancer | Human Necessities | 1 | Active |
| US8552048B2 | Phosphoramidate alkylator prodrugs for the treatment of cancer | Human Necessities | 1 | Active |
| US8318683B2 | Anti-cancer therapies | Human Necessities | 0 | Active |
| US9226932B2 | Phosphoramidate alkylator prodrugs | Human Necessities | 0 | Active |
| US8765690B2 | Treatment of cancer with glufosfamide in patients not receiving insulin therapy | Chemistry; Metallurgy | 0 | Active |
| US8309554B2 | Hypoxia activated drugs of nitrogen mustard alkylators | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.